Nanotech Investing Aerovate Therapeutics Presents Baseline Data from the Phase 2b Portion of the IMPAHCT Trial at the American Thoracic Society 2024 International Conference
Nanotech Investing Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights
